You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Details for Patent: 12,036,219


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 12,036,219 protect, and when does it expire?

Patent 12,036,219 protects BAXDELA and is included in one NDA.

This patent has seventeen patent family members in twelve countries.

Summary for Patent: 12,036,219
Title:Methods of treating infections in overweight and obese patients using antibiotics
Abstract:The present disclosure relates generally to methods of treating infections in overweight or obese patients using antibiotics. According to statistics compiled by National Health and Nutrition Examination Survey conducted by the National Center for Health Statistics (NCHS) of the U.S. Centers for Disease Control and Prevention (CDC), in 2009-2010, 35.7% of adults in the United States were found to be obese. Ogden, C.L. NCHS Data Brief 2012, 82, available at http://www.cdc.gov/nchs/data/databiefs/db82.pdf (last visited Mar. 2, 2013).
Inventor(s):Erin M. Duffy
Assignee:Melinta Subsidiary Corp
Application Number:US14/775,465
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a Patent: A Detailed Look at the Patent Landscape

Introduction to Patent Analysis

When analyzing a patent, such as the United States Patent 12,036,219, it is crucial to understand the scope and claims of the patent, as well as the broader patent landscape. This analysis helps in determining the patent's value, identifying potential infringement, and strategizing for future innovations.

Understanding Patent Claims

What are Patent Claims?

Patent claims are the most critical part of a patent application, as they define the scope of the invention and what is protected by the patent. These claims must be clear, concise, and specific to ensure that the invention is adequately protected[3].

Types of Claims

Patent claims can be divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. Understanding the hierarchy and interrelation of these claims is essential for a comprehensive analysis.

Analyzing the Scope of Patent 12,036,219

Claim Construction

To analyze the scope of a patent like 12,036,219, one must start with claim construction. This involves interpreting the language of the claims to determine their meaning and scope. The courts often use a two-step test, known as the "Alice test," to determine whether the claims are directed to patent-eligible subject matter. This test checks if the claims are directed to an abstract idea and if they include elements that transform them into a patent-eligible application[2].

Technological Improvements

For a patent to be valid, it must provide a technological improvement over the prior art. In the case of 12,036,219, if the claims describe a specific means that improves the relevant technology, they are more likely to be considered patent-eligible. For example, if the patent claims an improved method or device that overcomes specific technical challenges, it would be viewed favorably under the Alice test[2].

Patent Valuation Methods

Cost Approach

The cost approach to patent valuation considers the cost incurred to develop the patent. This includes research and development expenses, legal fees, and other costs associated with obtaining the patent. While this method provides a baseline, it does not account for the patent's future economic benefits[1].

Income Approach

The income approach values a patent based on its future economic benefits. This method calculates the present value of the income or savings generated by the patent over its lifetime. It is a more forward-looking approach and can provide a more accurate valuation if the future benefits are well-defined[1].

Market Approach

The market approach determines the value of a patent by looking at what similar patents have sold for in the market. This method uses sales and asking price data to estimate the value. For instance, if similar patents in the same technological field have sold for a median price of $108,000 per document, this could serve as a benchmark for valuing the patent in question[1].

Patent Analytics and Landscape

Claim Coverage Matrix

To understand the patent landscape, a Claim Coverage Matrix can be used. This tool categorizes patents by claims and scope concepts, helping to identify which patents and claims are actively protecting the intellectual property. It also highlights gaps or opportunities in the current coverage, which can be crucial for strategic planning and innovation[3].

Interactive Claim Charts

Interactive claim charts generated by tools like ClaimScape® software can facilitate a quick and accurate review of patent coverage. These charts help technical experts, engineers, and management to determine whether a particular scope concept is applicable to a target product or method. This approach ensures that the company's patent portfolio is aligned with its technological and business goals[3].

Industry Trends and Patent Activity

Technology Categories

Patent activity is often categorized into broader technological fields. For example, the ICT category, which includes computer technology, digital communication, semiconductors, and telecommunications, has a significant share of USPTO patents. Understanding these trends can help in positioning the patent within the broader industry context and identifying areas of high innovation and competition[4].

High-Technology Manufacturing

High-technology manufacturing industries, such as those in the fields of ICT, chemistry, and health, receive a substantial number of patents. These industries are more likely to engage in experimental development activities and have direct commercial applications for their inventions. This information can be useful in assessing the competitive landscape and the potential value of the patent[4].

Key Takeaways

  • Patent Claims: The claims are the heart of a patent and must be clearly defined to protect the invention.
  • Claim Construction: Understanding the meaning and scope of claims is crucial, often involving legal interpretations.
  • Patent Valuation: The cost, income, and market approaches provide different perspectives on a patent's value.
  • Patent Analytics: Tools like Claim Coverage Matrix and interactive claim charts help in managing and strategizing the patent portfolio.
  • Industry Trends: Understanding the broader technological and industry trends can help in positioning the patent and identifying opportunities.

FAQs

What is the primary purpose of patent claims?

The primary purpose of patent claims is to define the scope of the invention and what is protected by the patent.

How is the value of a patent determined?

The value of a patent can be determined using the cost, income, and market approaches, each providing a different perspective on the patent's worth.

What is the Alice test in patent law?

The Alice test is a two-step test used to determine whether patent claims are directed to patent-eligible subject matter, checking if the claims are directed to an abstract idea and if they include elements that transform them into a patent-eligible application.

How can patent analytics help in managing a patent portfolio?

Patent analytics tools, such as Claim Coverage Matrix and interactive claim charts, help in categorizing patents by claims and scope concepts, identifying gaps or opportunities, and aligning the patent portfolio with business and technological goals.

Which industries receive the most patents in the United States?

High-technology manufacturing industries, such as those in ICT, chemistry, and health, receive a significant number of patents due to their high engagement in experimental development activities and direct commercial applications.

Sources

  1. The Value of a Patent - Perpetual Motion Patents
  2. CONTOUR IP HOLDING LLC v. GOPRO, INC. - United States Court of Appeals for the Federal Circuit
  3. Patent Analytics - Schwegman, Lundberg & Woessner, P.A.
  4. Invention, Knowledge Transfer, and Innovation - National Science Foundation
  5. SUBPART 227.70 INFRINGEMENT CLAIMS, LICENSES, AND ... - U.S. Department of Defense

More… ↓

⤷  Try for Free


Recent additions to Drugs Protected by US Patent 12,036,219

These patents are from the daily update and have not yet been integrated into the regular database
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist Req. Patent Expiration Usecode Patented / Exclusive Use
Melinta BAXDELA delafloxacin meglumine POWDER 208611 Jun 19, 2017 RX Yes 12,036,219 ⤷  Try for Free U-3967 TREATING AN ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION (ABSSSI) IN AN OVERWEIGHT OR OBESE PATIENT BY INTRAVENOUSLY (IV) ADMINISTERING 300MG OF DELAFLOXACIN OR A PHARMACEUTICALLY ACCEPTABLE SALT, TWICE A DAY
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Product >Substance >Delist Req. >Patent Expiration >Usecode >Patented / Exclusive Use

Drugs Protected by US Patent 12,036,219

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Melinta BAXDELA delafloxacin meglumine POWDER;INTRAVENOUS 208611-001 Jun 19, 2017 RX Yes Yes 12,036,219 ⤷  Try for Free TREATING AN ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION (ABSSSI) IN AN OVERWEIGHT OR OBESE PATIENT BY INTRAVENOUSLY (IV) ADMINISTERING 300MG OF DELAFLOXACIN OR A PHARMACEUTICALLY ACCEPTABLE SALT, TWICE A DAY ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.